Isicelo esitsha seChiza soNyango oluPhezulu lweMigraine

Ngamana 2, 2022
by Linda Hohnholz
2 imiz efundwayo
A BAMBA isiKhululo sasimahla 5 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

Axsome Therapeutics, Inc. today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for AXS-07 for the acute treatment of migraine. The CRL did not identify or raise any concerns about the clinical efficacy or safety data in the…

eTurboNews amanqaku ngababhalisi kuphela. Umrhumo ngu fREE.
Ababhalisi bangena apha Cofa apha ukuze ubhalise FREE

INTO ONOKUYITHATHA KWELI NQAKU:

  • today announced that the Company has received a Complete Response Letter (CRL) from the U.
  • The CRL did not identify or raise any concerns about the clinical efficacy or safety data in the….
  • Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for AXS-07 for the acute treatment of migraine.
ushicileloLinkedInyocingoWhatsAppVKMessengeri-SMSRedditFlipboardTwilleyTumblrXingBomgciniHacker NewsumgcaxubaPocketYummlyikopi

<

Ungathanda

Malunga nombhali

Linda Hohnholz

Umhleli oyintloko we eTurboNews esekwe kwi-eTN HQ.

Jonga zonke izithuba
Yabelana ku...
BomgciniikopiFlipboardHacker NewsumgcaLinkedInMessengerxubaTwilleyPocketushicileloRedditi-SMSyocingoTumblrVKWhatsAppXing